KOBAYASHI Pharmaceutical
4967.T
$64.38
Share price
-0.66%
Change (1 day)
2.96%
Change (1 year)
Categories
Revenue for KOBAYASHI Pharmaceutical (4967.T)
Revenue in 2024 (TTM): NZ$1.81 Billion
According to KOBAYASHI Pharmaceutical's latest financial reports the company's current revenue (TTM 
) is NZ$1.86 Billion. a decrease over the revenue in the year 2023 that were of NZ$1.92 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for KOBAYASHI Pharmaceutical from 2009 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | NZ$1.92 B | -0.24% |
| 2023 | NZ$1.92 B | -1.78% |
| 2022 | NZ$1.96 B | -3.17% |
| 2021 | NZ$2.02 B | 2.74% |
| 2020 | NZ$1.97 B | -12.88% |
| 2019 | NZ$2.26 B | 0.11% |
| 2018 | NZ$2.26 B | 15.05% |
| 2017 | NZ$1.96 B | |
| 2015 | NZ$1.64 B | 8.74% |
| 2014 | NZ$1.51 B | 0.89% |
| 2013 | NZ$1.49 B | -18.21% |
| 2012 | NZ$1.83 B | -13.67% |
| 2011 | NZ$2.12 B | 9.05% |
| 2010 | NZ$1.94 B | 2.95% |
| 2009 | NZ$1.89 B |